Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

AB825

Sigma-Aldrich

Anti-Apolipoprotein J Antibody

Chemicon®, from goat

Sinonimo/i:

Clusterin, ApoJ

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41

Origine biologica

goat

Livello qualitativo

Forma dell’anticorpo

affinity purified immunoglobulin

Tipo di anticorpo

primary antibodies

Clone

polyclonal

Purificato mediante

affinity chromatography

Reattività contro le specie

human

Produttore/marchio commerciale

Chemicon®

tecniche

ELISA: suitable
immunohistochemistry: suitable (paraffin)
immunoprecipitation (IP): suitable
western blot: suitable

N° accesso NCBI

N° accesso UniProt

Condizioni di spedizione

wet ice

modifica post-traduzionali bersaglio

unmodified

Informazioni sul gene

human ... CLU(1191)

Specificità

Apolipoprotein J, Human. Negligible cross reactivity to Apo A-I, A-II, B, C-I, C-II, C-III, and E by ELISA. Negligible non-specific cross-reaction with other human serum proteins.

Immunogeno

Apolipoprotein J, purified from human plasma.

Applicazioni

Anti-Apolipoprotein J Antibody is an antibody against Apolipoprotein J for use in ELISA, IP, WB, IH(P).
Immunoblotting: 1:5,000-1:10,000

Immunohistochemistry on paraffin embedded tissue: 1:50-1:200

Immunoprecipitation

ELISA: 1:5,000-1:10,000

Optimal working dilutions must be determined by end user.
Research Category
Metabolism
Research Sub Category
Lipid Metabolism & Weight Regulation

Stato fisico

Affinity purified immunoglobulin. Liquid in 0.125 M Sodium Borate buffer, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0, with 0.01% sodium azide.

Stoccaggio e stabilità

Maintain at 2-8°C in undiluted aliquots for several weeks. For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20°C or below for up to 12 months. Avoid repeated freeze/thaw cycles.

Altre note

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Note legali

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Esclusione di responsabilità

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Motore di ricerca dei prodotti.

Raccomandato

N° Catalogo
Descrizione
Determinazione del prezzo

Pittogrammi

Health hazard

Avvertenze

Danger

Indicazioni di pericolo

Classi di pericolo

Repr. 1B

Codice della classe di stoccaggio

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

N Bahia El Idrissi et al.
Clinical and experimental immunology, 184(3), 338-346 (2016-01-11)
Mycobacterium leprae infection gives rise to the immunologically and histopathologically classified spectrum of leprosy. At present, several tools for the stratification of patients are based on acquired immunity markers. However, the role of innate immunity, particularly the complement system, is
Svetlana Hakobyan et al.
Journal of Alzheimer's disease : JAD, 54(2), 707-716 (2016-08-29)
There is a critical unmet need for reliable markers of disease and disease course in mild cognitive impairment (MCI) and early Alzheimer's disease (AD). The growing appreciation of the importance of inflammation in early AD has focused attention on inflammatory
Samantha L Hersrud et al.
The FEBS journal, 283(3), 459-471 (2015-11-14)
The neuronal ceroid lipofuscinoses (NCLs) are a group of neurodegenerative genetic diseases that primarily affect children and have no known cure. A unified clinical rating scale for the juvenile form of NCL has been developed, although it has not been
Chera L Maarouf et al.
PloS one, 6(11), e27291-e27291 (2011-11-17)
The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades. If amyloid accumulation is
Chera L Maarouf et al.
PloS one, 9(8), e105784-e105784 (2014-08-29)
Defining the biochemical alterations that occur in the brain during "normal" aging is an important part of understanding the pathophysiology of neurodegenerative diseases and of distinguishing pathological conditions from aging-associated changes. Three groups were selected based on age and on

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.